Skip to main content

Sean Maduck

Equibles does not estimate personal net worth.

About Sean Maduck

Corcept Therapeutics Inc reported in an 8-K filed September 23, 2026 that Sean Maduck resigned as President of Corcept Endocrinology, effective October 1, 2026. The proxy statement of Corcept Therapeutics Inc reports total compensation of $6,208,642 for Sean Maduck in fiscal 2025, including a base salary of $648,860. Disclosed compensation is on record for 9 fiscal years. Sean Maduck has spoken on 2 earnings calls across 1 company, most recently for Corcept Therapeutics Inc on April 30, 2026. The companies whose calls Sean Maduck spoke on are classified in the Healthcare sector.

“On September 22, 2026, Sean Maduck, the President of Corcept Endocrinology, notified the Board of Directors of Corcept Therapeutics Incorporated (the "Company") of his decision to resign effective as of October 1, 2026.”
Corcept Therapeutics Inc Form 8-K, filed September 23, 2026 · Read the filing

Sean Maduck on recent calls

“Demand for our medications continues to increase. We ended the first quarter with a record number of new prescriptions written from a record number of prescribers, which translated to an all-time high for the number of patients receiving our medications.”
Other, Corcept Therapeutics Inc Q1 FY2026 Earnings Call ·
“Our Cushing Syndrome business experienced a surge in demand in 2025. We saw a record number of new prescriptions for our medications and a record number of first-time prescribers.”
Other, Corcept Therapeutics Inc Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Corcept Therapeutics Inc (CORT) $648,860 $6,208,642
2024 Corcept Therapeutics Inc (CORT) $626,148 $3,971,171
2023 Corcept Therapeutics Inc (CORT) $601,583 $3,908,931
2022 Corcept Therapeutics Inc (CORT) $572,917 $3,714,056
2021 Corcept Therapeutics Inc (CORT) $519,451 $4,545,181
2020 Corcept Therapeutics Inc (CORT) $474,380 $3,196,941
2019 Corcept Therapeutics Inc (CORT) $456,133 $2,241,290
2018 Corcept Therapeutics Inc (CORT) $436,667 $2,806,067
2017 Corcept Therapeutics Inc (CORT) $397,917 $2,754,735

Recent activity